Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Modulation of Hypoglossal Motor Pool Excitability Across Sleep-Wake States by TASK Channels

EF 2017-18

Résumé
Obstuctive sleep apnea (OSA) is a common and serious disorder characterized by frequent interruptions of breathing during sleep, which leads to complications such as excessive sleepiness, hypertension and cardiovascular disease. Estimates show that 3-9% of women and 10-17% of men are affected with this disorder, many of which are undiagnosed due to its occurrence during sleep. The primary cause of OSA is a decrease in tongue muscle activity; when awake, the brain releases awake-active chemicals that keep the tongue muscle active. As the levels of these chemicals fall during sleep, however, the tongue falls into the back of the throat and blocks the airway, leading to interruptions in breathing. The goal of this project is to identify those mechanisms in the brain involved in controlling the tongue muscle, and to determine new ways to increase tongue muscle activity during sleep to prevent airway blockade. To accomplish this, we plan to use an FDA-approved drug, doxapram, and observe its effects when administered to the brain region involved in tongue muscle control. There is evidence that doxapram may mimic the effects of those awake-active chemicals in increasing the excitability of this brain region. By administering this drug during sleep, we believe that we can prevent the normal decrease in this brain region's excitability that occurs during sleep and maintain waking tongue muscle activity. There is currently no pharmacological treatment for this disorder. People who have been diagnosed are advised to wear a mechanical pressure device over their nose and mouth while they sleep to prevent airway collapse, an outcome which is not ideal. Our research may provide the mechanistic validation for the development of new drugs to treat OSA.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386651
Name
Gurges Patrick
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modulation of Hypoglossal Motor Pool Excitability Across Sleep-Wake States by TASK Channels
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Genioglossus; Hypoglossal Nucleus; K+ Channels; Neuroscience; Obstructive Sleep Apnea; Optogenetics; Pharmacology; Respiration; Sleep Science; Upper Airway
Abstract
Obstuctive sleep apnea (OSA) is a common and serious disorder characterized by frequent interruptions of breathing during sleep, which leads to complications such as excessive sleepiness, hypertension and cardiovascular disease. Estimates show that 3-9% of women and 10-17% of men are affected with this disorder, many of which are undiagnosed due to its occurrence during sleep. The primary cause of OSA is a decrease in tongue muscle activity; when awake, the brain releases awake-active chemicals that keep the tongue muscle active. As the levels of these chemicals fall during sleep, however, the tongue falls into the back of the throat and blocks the airway, leading to interruptions in breathing. The goal of this project is to identify those mechanisms in the brain involved in controlling the tongue muscle, and to determine new ways to increase tongue muscle activity during sleep to prevent airway blockade. To accomplish this, we plan to use an FDA-approved drug, doxapram, and observe its effects when administered to the brain region involved in tongue muscle control. There is evidence that doxapram may mimic the effects of those awake-active chemicals in increasing the excitability of this brain region. By administering this drug during sleep, we believe that we can prevent the normal decrease in this brain region's excitability that occurs during sleep and maintain waking tongue muscle activity. There is currently no pharmacological treatment for this disorder. People who have been diagnosed are advised to wear a mechanical pressure device over their nose and mouth while they sleep to prevent airway collapse, an outcome which is not ideal. Our research may provide the mechanistic validation for the development of new drugs to treat OSA.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gurges, Patrick
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~